Victory Capital Management Inc. Acquires 528,849 Shares of Kenvue Inc. (NYSE:KVUE)

Victory Capital Management Inc. lifted its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 66.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,328,074 shares of the company's stock after acquiring an additional 528,849 shares during the period. Victory Capital Management Inc. owned 0.07% of Kenvue worth $30,718,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Leo Wealth LLC increased its holdings in shares of Kenvue by 0.3% in the third quarter. Leo Wealth LLC now owns 151,611 shares of the company's stock valued at $3,507,000 after purchasing an additional 481 shares during the period. Massmutual Trust Co. FSB ADV increased its stake in shares of Kenvue by 6.2% during the third quarter. Massmutual Trust Co. FSB ADV now owns 8,400 shares of the company's stock worth $194,000 after acquiring an additional 492 shares during the period. Wolff Wiese Magana LLC increased its position in Kenvue by 0.7% during the 3rd quarter. Wolff Wiese Magana LLC now owns 76,999 shares of the company's stock worth $1,781,000 after purchasing an additional 501 shares during the period. Marathon Capital Management raised its stake in shares of Kenvue by 0.3% during the 2nd quarter. Marathon Capital Management now owns 149,699 shares of the company's stock worth $2,722,000 after buying an additional 514 shares in the last quarter. Finally, Poehling Capital Management INC. lifted its holdings in shares of Kenvue by 0.5% in the 2nd quarter. Poehling Capital Management INC. now owns 104,934 shares of the company's stock valued at $1,908,000 after buying an additional 547 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on KVUE. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Kenvue from $23.00 to $24.00 and gave the stock a "buy" rating in a report on Wednesday, August 7th. Jefferies Financial Group started coverage on Kenvue in a report on Tuesday, September 24th. They issued a "buy" rating and a $27.00 price target on the stock. JPMorgan Chase & Co. lifted their price objective on Kenvue from $24.00 to $25.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Royal Bank of Canada lowered Kenvue from an "outperform" rating to a "sector perform" rating and set a $24.00 target price on the stock. in a report on Tuesday, September 24th. Finally, Bank of America raised their price target on Kenvue from $24.00 to $27.00 and gave the company a "buy" rating in a research report on Tuesday, October 22nd. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $22.64.

Kenvue Price Performance

Shares of NYSE KVUE traded up $0.21 during mid-day trading on Friday, reaching $23.82. The company had a trading volume of 16,167,897 shares, compared to its average volume of 17,109,668. The company has a 50-day moving average price of $22.77 and a two-hundred day moving average price of $20.70. The stock has a market cap of $45.67 billion, a PE ratio of 43.31, a P/E/G ratio of 2.16 and a beta of 1.36. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.13.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.28 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.01. The firm had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The company's revenue was down .4% on a year-over-year basis. During the same quarter last year, the business posted $0.31 EPS. On average, equities analysts anticipate that Kenvue Inc. will post 1.07 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th will be given a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.44%. The ex-dividend date of this dividend is Wednesday, November 13th. Kenvue's dividend payout ratio is 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.